Roivant Sciences (ROIV) Change in Acquisitions & Divestments (2020 - 2026)
Roivant Sciences' (ROIV) quarterly Change in Acquisitions & Divestments came in at $2.7 billion in Q4 2025, up 185.94% YoY from $960.0 million in Q4 2024, and up 148.42% on a QoQ basis from $1.1 billion in Q3 2025.
Roivant Sciences (ROIV) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends
Roivant Sciences (ROIV) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $2.7 billion in Q4 2025.
- Quarterly Change in Acquisitions & Divestments rose 185.94% year-over-year to $2.7 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.5 billion (up 476.04% YoY) and the FY2026 annual result came in at $2.2 billion, changed N/A from the prior year.
- Change in Acquisitions & Divestments grew to $2.7 billion in Q4 2025, from $1.1 billion in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $2.7 billion in Q4 2025 to a low of $320.2 million in Q4 2021.
- A 3-year average of $1.2 billion and a median of $960.0 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2021 — Change in Acquisitions & Divestments surged 200.0% — and 2025, when it surged 185.94%.
- Tracing ROIV's Change in Acquisitions & Divestments over 3 years: stood at $320.2 million in 2021, then surged by 199.84% to $960.0 million in 2024, then surged by 185.94% to $2.7 billion in 2025.
- The last three Change in Acquisitions & Divestments figures came in at $2.7 billion (Q4 2025), $1.1 billion (Q3 2025), and $720.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 568.19 Mn |
| Jun 30, 2026 | 568.19 Mn |
| Dec 31, 2025 | 2.75 Bn |
| Dec 31, 2025 | 2.75 Bn |
| Sep 30, 2025 | 1.11 Bn |
| Sep 30, 2025 | 1.11 Bn |
| Jun 30, 2025 | 720.00 Mn |
| Jun 30, 2025 | 720.00 Mn |
| Dec 31, 2024 | 960.00 Mn |
| Dec 31, 2024 | 960.00 Mn |
| Dec 31, 2021 | 320.17 Mn |
| Dec 31, 2021 | 320.17 Mn |
| Dec 31, 2020 | -320.17 Mn |
| Dec 31, 2020 | -320.17 Mn |